• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂多糖刺激细胞因子分泌对转移性非小细胞肺癌的预测和预后价值。

Predictive and prognostic value of LPS-stimulated cytokine secretion in metastatic non-small cell lung cancer.

机构信息

Department of Medical Oncology, Faculty of Medicine, University of Thessaly, University Hospital of Larissa, Biopolis, Larissa, 41110, Greece,

出版信息

Clin Transl Oncol. 2013 Nov;15(11):903-9. doi: 10.1007/s12094-013-1021-5. Epub 2013 Mar 5.

DOI:10.1007/s12094-013-1021-5
PMID:23463594
Abstract

OBJECTIVE

Cancer patients usually develop malnutrition which may alter their innate immune system integrity. The aim of this study was to investigate the clinical relevance of chemokine response after lipopolysaccharide (LPS)-stimulation in metastatic non-small cell lung cancer (NSCLC).

METHODS

Blood samples from metastatic NSCLC patients were incubated with LPS before the onset of systemic therapy. Interleukin (IL)-6 and IL-8 levels at baseline and after LPS-stimulation were measured and the fold change compared to baseline levels was evaluated as the stimulation index for each cytokine per patient. Results were correlated with sex, age, smoking status, histologic subtype, performance status (PS), albumin, Mini Nutritional Assessment (MNA) status and clinical outcomes.

RESULTS

Totally 103 patients were evaluated. Mean (±SD) stimulation index was 37.6 (±57.8) for IL-6 and 76.7 (±133.4) for IL-8. The disease control rate after first-line chemotherapy was 44/80 (55 %) and the mean (±SD) progression-free survival (PFS) and overall survival (OS) were 4.2 (±3.9) and 9.2 (±1.1) months, respectively. MNA, PS, albumin, IL-6 and IL-8 stimulation indices were univariately associated with PFS and OS. IL-8 stimulation index emerged as an independent predictor of both PFS and OS, along with PS, and albumin levels.

CONCLUSION

The extent of IL-6 and IL-8 stimulation after ex vivo induction with LPS is an important predictor of clinical outcome in metastatic NSCLC patients.

摘要

目的

癌症患者通常会出现营养不良,这可能会改变其固有免疫系统的完整性。本研究旨在探讨脂多糖(LPS)刺激后转移性非小细胞肺癌(NSCLC)患者趋化因子反应的临床相关性。

方法

在开始全身治疗之前,将转移性 NSCLC 患者的血液样本与 LPS 孵育。测量基线时和 LPS 刺激后白细胞介素(IL)-6 和 IL-8 水平,并评估每个患者每种细胞因子相对于基线水平的变化倍数作为刺激指数。结果与性别、年龄、吸烟状况、组织学亚型、表现状态(PS)、白蛋白、迷你营养评估(MNA)状况和临床结果相关。

结果

共评估了 103 例患者。IL-6 的平均(±SD)刺激指数为 37.6(±57.8),IL-8 为 76.7(±133.4)。一线化疗后的疾病控制率为 44/80(55%),平均(±SD)无进展生存期(PFS)和总生存期(OS)分别为 4.2(±3.9)和 9.2(±1.1)个月。MNA、PS、白蛋白、IL-6 和 IL-8 刺激指数与 PFS 和 OS 均呈单变量相关。IL-8 刺激指数与 PS 和白蛋白水平一起,是 PFS 和 OS 的独立预测因子。

结论

LPS 体外诱导后 IL-6 和 IL-8 的刺激程度是转移性 NSCLC 患者临床结局的重要预测因子。

相似文献

1
Predictive and prognostic value of LPS-stimulated cytokine secretion in metastatic non-small cell lung cancer.脂多糖刺激细胞因子分泌对转移性非小细胞肺癌的预测和预后价值。
Clin Transl Oncol. 2013 Nov;15(11):903-9. doi: 10.1007/s12094-013-1021-5. Epub 2013 Mar 5.
2
Pretreatment Serum Albumin Level is an Independent Prognostic Factor in Patients with Stage IIIB Non-Small Cell Lung Cancer: A Study of the Turkish Descriptive Oncological Researches Group.治疗前血清白蛋白水平是ⅢB期非小细胞肺癌患者的独立预后因素:土耳其描述性肿瘤学研究组的一项研究
Asian Pac J Cancer Prev. 2015;16(14):5971-6. doi: 10.7314/apjcp.2015.16.14.5971.
3
Circulating interleukin-6 level is a prognostic marker for survival in advanced nonsmall cell lung cancer patients treated with chemotherapy.循环白细胞介素-6 水平是化疗治疗晚期非小细胞肺癌患者生存的预后标志物。
Int J Cancer. 2013 May 1;132(9):1977-85. doi: 10.1002/ijc.27892. Epub 2012 Oct 29.
4
Circulating endothelial cells in non-small cell lung cancer patients treated with carboplatin and paclitaxel.接受卡铂和紫杉醇治疗的非小细胞肺癌患者的循环内皮细胞
J Thorac Oncol. 2009 Feb;4(2):208-13. doi: 10.1097/JTO.0b013e318193030d.
5
Elevated lactic acid is a negative prognostic factor in metastatic lung cancer.乳酸水平升高是转移性肺癌的一个不良预后因素。
Cancer Biomark. 2015;15(6):725-34. doi: 10.3233/CBM-150514.
6
Baseline plasma levels of interleukin-8 in stage IV non-small-cell lung cancer patients: relationship with nutritional status and prognosis.IV 期非小细胞肺癌患者基线血浆白细胞介素-8 水平:与营养状况和预后的关系。
Nutr Cancer. 2012;64(1):41-7. doi: 10.1080/01635581.2012.630157. Epub 2011 Nov 18.
7
The value of serum Bcl-2 levels in advanced lung cancer patients.晚期肺癌患者血清Bcl-2水平的价值
Med Oncol. 2005;22(2):139-43. doi: 10.1385/MO:22:2:139.
8
Research on the relationship between serum levels of inflammatory cytokines and non-small cell lung cancer.血清炎症细胞因子水平与非小细胞肺癌关系的研究
Asian Pac J Cancer Prev. 2013;14(8):4765-8. doi: 10.7314/apjcp.2013.14.8.4765.
9
Circulating free DNA concentration is an independent prognostic biomarker in lung cancer.循环游离 DNA 浓度是肺癌的独立预后生物标志物。
Eur Respir J. 2015 Dec;46(6):1773-80. doi: 10.1183/13993003.00676-2015. Epub 2015 Oct 22.
10
VEGF and TSP1 levels correlate with prognosis in advanced non-small cell lung cancer.VEGF 和 TSP1 水平与晚期非小细胞肺癌的预后相关。
Clin Transl Oncol. 2013 Nov;15(11):897-902. doi: 10.1007/s12094-013-1020-6. Epub 2013 Mar 5.

引用本文的文献

1
Comprehensive bioinformatics analysis of malignant transformation and potential therapeutic possibility of lung adenocarcinoma after lipopolysaccharide induction.脂多糖诱导后肺腺癌恶性转化及潜在治疗可能性的综合生物信息学分析
Front Genet. 2025 Jul 8;16:1556366. doi: 10.3389/fgene.2025.1556366. eCollection 2025.
2
Modulating the tumor microenvironment: The role of traditional Chinese medicine in improving lung cancer treatment.调节肿瘤微环境:中药在改善肺癌治疗中的作用。
Open Life Sci. 2025 May 20;20(1):20251100. doi: 10.1515/biol-2025-1100. eCollection 2025.
3
IL-8 and its role as a potential biomarker of resistance to anti-angiogenic agents and immune checkpoint inhibitors in metastatic renal cell carcinoma.

本文引用的文献

1
Activated expression of the chemokine Mig after chemotherapy contributes to chemotherapy-induced bone marrow suppression and lethal toxicity.化疗后趋化因子 Mig 的激活表达导致化疗引起的骨髓抑制和致命毒性。
Blood. 2012 May 24;119(21):4868-77. doi: 10.1182/blood-2011-07-367581. Epub 2012 Apr 3.
2
Cancer statistics, 2012.癌症统计数据,2012 年。
CA Cancer J Clin. 2012 Jan-Feb;62(1):10-29. doi: 10.3322/caac.20138. Epub 2012 Jan 4.
3
Baseline plasma levels of interleukin-8 in stage IV non-small-cell lung cancer patients: relationship with nutritional status and prognosis.
白细胞介素-8及其作为转移性肾细胞癌中抗血管生成药物和免疫检查点抑制剂耐药潜在生物标志物的作用。
Front Oncol. 2022 Aug 19;12:990568. doi: 10.3389/fonc.2022.990568. eCollection 2022.
4
Relationship between Nutritional Status and Clinical Outcome in Patients Treated for Lung Cancer.肺癌患者营养状况与临床结局的关系。
Nutrients. 2021 Sep 23;13(10):3332. doi: 10.3390/nu13103332.
5
Salidroside Suppresses the Proliferation and Migration of Human Lung Cancer Cells through AMPK-Dependent NLRP3 Inflammasome Regulation.红景天苷通过 AMPK 依赖性 NLRP3 炎性小体调节抑制人肺癌细胞的增殖和迁移。
Oxid Med Cell Longev. 2021 Aug 19;2021:6614574. doi: 10.1155/2021/6614574. eCollection 2021.
6
LPS Enhances the Chemosensitivity of Oxaliplatin in HT29 Cells via GSDMD-Mediated Pyroptosis.脂多糖通过Gasdermin D介导的细胞焦亡增强HT29细胞对奥沙利铂的化疗敏感性。
Cancer Manag Res. 2020 Oct 20;12:10397-10409. doi: 10.2147/CMAR.S244374. eCollection 2020.
7
Nutritional status according to the mini nutritional assessment (MNA)® as potential prognostic factor for health and treatment outcomes in patients with cancer - a systematic review.根据迷你营养评估 (MNA)®评估的营养状况作为癌症患者健康和治疗结果的潜在预后因素 - 系统评价。
BMC Cancer. 2020 Jun 26;20(1):594. doi: 10.1186/s12885-020-07052-4.
8
Hydroxysafflor yellow A inhibited lipopolysaccharide-induced non-small cell lung cancer cell proliferation, migration, and invasion by suppressing the PI3K/AKT/mTOR and ERK/MAPK signaling pathways.羟基红花黄色素 A 通过抑制 PI3K/AKT/mTOR 和 ERK/MAPK 信号通路抑制脂多糖诱导的非小细胞肺癌细胞增殖、迁移和侵袭。
Thorac Cancer. 2019 Jun;10(6):1319-1333. doi: 10.1111/1759-7714.13019. Epub 2019 May 4.
IV 期非小细胞肺癌患者基线血浆白细胞介素-8 水平:与营养状况和预后的关系。
Nutr Cancer. 2012;64(1):41-7. doi: 10.1080/01635581.2012.630157. Epub 2011 Nov 18.
4
Regulation of cancer stem cells by cytokine networks: attacking cancer's inflammatory roots.细胞因子网络对癌症干细胞的调控:从炎症根源处攻克癌症。
Clin Cancer Res. 2011 Oct 1;17(19):6125-9. doi: 10.1158/1078-0432.CCR-10-2743. Epub 2011 Jun 17.
5
Increased levels of circulating interleukin 6, interleukin 8, C-reactive protein, and risk of lung cancer.循环白细胞介素 6、白细胞介素 8、C 反应蛋白水平升高与肺癌风险增加有关。
J Natl Cancer Inst. 2011 Jul 20;103(14):1112-22. doi: 10.1093/jnci/djr216. Epub 2011 Jun 17.
6
Mini Nutritional Assessment (MNA) and biochemical markers of cachexia in metastatic lung cancer patients: interrelations and associations with prognosis.Mini 营养评估 (MNA) 和转移性肺癌患者恶病质的生化标志物:相互关系及其与预后的关联。
Lung Cancer. 2011 Dec;74(3):516-20. doi: 10.1016/j.lungcan.2011.05.009. Epub 2011 May 31.
7
Antitumor effect of inhalatory lipopolysaccharide and synergetic effect in combination with cyclophosphamide.吸入性脂多糖的抗肿瘤作用及其与环磷酰胺的协同作用。
Anticancer Res. 2010 Aug;30(8):3129-34.
8
Serum cytokine levels in patients with advanced non-small cell lung cancer: correlation with treatment response and survival.晚期非小细胞肺癌患者的血清细胞因子水平:与治疗反应和生存的相关性。
Med Oncol. 2011 Dec;28(4):1453-7. doi: 10.1007/s12032-010-9645-6. Epub 2010 Aug 17.
9
Cancer cachexia.癌症恶病质。
Curr Opin Gastroenterol. 2010 Mar;26(2):146-51. doi: 10.1097/MOG.0b013e3283347e77.
10
Characteristics of PBMC obtained from leukapheresis products and tumor biopsies of patients with non-small cell lung cancer.从非小细胞肺癌患者的白细胞分离产物和肿瘤活检中获得的 PBMC 的特征。
Oncol Rep. 2009 Dec;22(6):1459-71. doi: 10.3892/or_00000588.